サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：着床前遺伝子診断市場レポート：2030年までの動向、予測、競合分析
市場調査レポート
商品コード
1356801

着床前遺伝子診断市場レポート：2030年までの動向、予測、競合分析

Preimplantation Genetics Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

着床前遺伝子診断市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

着床前遺伝子診断の動向と予測

着床前遺伝学診断の世界市場は、2024年から2030年までのCAGRが10.7％で、2030年までに推定2億米ドルに達すると予想されます。この市場の主な促進要因は、遺伝性疾患の有病率の上昇、生殖医療における遺伝学の役割に対する意識の高まり、不妊治療における技術の進歩です。着床前遺伝子診断の世界市場は、診断ラボ、病院、クリニック市場においてビジネスチャンスがあり、将来性が期待されます。

着床前遺伝子診断市場の洞察

  • Lucintelの予測では、異数性スクリーニング法の採用が増加し、新製品が市場にイントロダクションされるため、予測期間中に異数性が最も高い成長を遂げる見込みです。
  • 病院は、患者の入院の増加、医療インフラの改善、公立病院だけでなく私立病院もこの地域にあることから、最大のセグメントであり続けると思われます。
  • APACは、体外受精の導入が増加していること、また同地域の人々の体外受精に対する意識が高まっていることから、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の着床前遺伝診断市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の着床前遺伝診断市場動向（2018～2023年）と予測（2024～2030年）
  • タイプ別の世界の着床前遺伝診断市場
    • 染色体異常
    • 異数性
    • X関連疾患
    • 単一遺伝子疾患
    • HLAのタイピング
    • 性別の選択
    • その他
  • 最終用途別の世界の着床前遺伝子診断市場
    • 診断研究所
    • 病院
    • クリニック
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の着床前遺伝診断市場
  • 北米の着床前遺伝診断市場
  • 欧州の着床前遺伝診断市場
  • アジア太平洋の着床前遺伝診断市場
  • その他地域着床前遺伝診断市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • タイプ別の世界の着床前遺伝子診断市場の成長機会
    • 最終用途別の世界の着床前遺伝子診断市場の成長機会
    • 地域別の世界の着床前遺伝子診断市場の成長機会
  • 世界の着床前遺伝子診断市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の着床前遺伝子診断市場の能力拡大
    • 世界の着床前遺伝子診断市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • PerkinElmer Agilent Technologies
  • Cegat
  • Laboratory Corporation of America Holdings
  • Illumina
  • Invitae Corporation
  • Pacgenomics
  • Quest Diagnostics
  • Natera
  • Reproductive Genetic Innovations（RGI）
目次

Preimplantation Genetics Diagnosis Trends and Forecast

The future of the global preimplantation genetics diagnosis market looks promising with opportunities in the diagnostic laboratory, hospital, and clinic markets. The global preimplantation genetics diagnosis market is expected to reach an estimated $0.20 billion by 2030 with a CAGR of 10.7% from 2024 to 2030. The major drivers for this market are rising prevalence of genetic disorder, growing awareness about the role of genetics in reproductive health, and technological advancement in the fertility treatments.

A more than 150-page report is developed to help in your business decisions.

Preimplantation Genetics Diagnosis by Segment

The study includes a forecast for the global preimplantation genetics diagnosis by type, end use, and region.

Preimplantation Genetics Diagnosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Chromosomal Abnormalities
  • Aneuploidy
  • X-linked diseases
  • Single Gene Disorders
  • HLA Typing
  • Gender selection
  • Others

Preimplantation Genetics Diagnosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic Laboratories
  • Hospitals
  • Clinics
  • Others

Preimplantation Genetics Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Preimplantation Genetics Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies preimplantation genetics diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the preimplantation genetics diagnosis companies profiled in this report include-

  • Perkinelmer Agilent Technologies
  • Cegat
  • Laboratory Corporation Of America Holdings
  • Illumina
  • Invitae Corporation
  • Pacgenomics
  • Quest Diagnostics
  • Natera
  • Reproductive Genetic Innovations (Rgi)

Preimplantation Genetics Diagnosis Market Insights

  • Lucintel forecasts that aneuploidy is expected to witness highest growth over the forecast period due to the growing adoption of aneuploidy screening methods and the introduction of novel products into the market.
  • Hospitals will remain the largest segment due to increasing admissions of patients, improvement in healthcare infrastructure, and availability of public as well as private hospitals in the region.
  • APAC is expected to witness highest growth over the forecast period due to increasing adoption of IVF translates and growing awaeness levels among people in the region.

Features of the Global Preimplantation Genetics Diagnosis Market

  • Market Size Estimates: Preimplantation genetics diagnosis market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Preimplantation genetics diagnosis market size by type, end use, and region. in terms of value ($B).
  • Regional Analysis: Preimplantation genetics diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, end uses, and region.s for the preimplantation genetics diagnosis market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the preimplantation genetics diagnosis market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the preimplantation genetics diagnosis market size?

Answer: The global preimplantation genetics diagnosis market is expected to reach an estimated $0.20 billion by 2030.

Q.2. What is the growth forecast for preimplantation genetics diagnosis market?

Answer: The global preimplantation genetics diagnosis market is expected to grow with a CAGR of 10.7% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the preimplantation genetics diagnosis market?

Answer: The major drivers for this market are rising prevalence of genetic disorder, growing awareness about the role of genetics in reproductive health, and technological advancement in the fertility treatments.

Q.4. What are the major segments for preimplantation genetics diagnosis market?

Answer: The future of the preimplantation genetics diagnosis market looks promising with opportunities in the diagnostic laboratory, hospital, and clinic markets.

Q.5. Who are the key Preimplantation Genetics Diagnosis Market companies?

Answer: Some of the key preimplantation genetics diagnosis companies are as follows:

  • PerkinElmer Agilent Technologies
  • Cegat
  • Laboratory Corporation of America Holdings
  • Illumina
  • Invitae Corporation
  • Pacgenomics
  • Quest Diagnostics
  • Natera
  • Reproductive Genetic Innovations (RGI)

Q.6. Which preimplantation genetics diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that aneuploidy is expected to witness highest growth over the forecast period due to the growing adoption of aneuploidy screening methods and the introduction of novel products into the market.

Q.7. In preimplantation genetics diagnosis market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing adoption of IVF translates and growing awaeness levels among people in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the preimplantation genetics diagnosis market by type (chromosomal abnormalities, aneuploidy, X-linked diseases,single gene disorders, HLA typing, gender selection, and others), end use (diagnostic laboratories, hospitals, clinics, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Preimplantation Genetics Diagnosis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Preimplantation Genetics Diagnosis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Preimplantation Genetics Diagnosis Market by Type
    • 3.3.1: Chromosomal Abnormalities
    • 3.3.2: Aneuploidy
    • 3.3.3: X-linked Diseases
    • 3.3.4: Single Gene Disorders
    • 3.3.5: HLA Typing
    • 3.3.6: Gender Selection
    • 3.3.7: Others
  • 3.4: Global Preimplantation Genetics Diagnosis Market by End Use
    • 3.4.1: Diagnostic Laboratories
    • 3.4.2: Hospitals
    • 3.4.3: Clinics
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Preimplantation Genetics Diagnosis Market by Region
  • 4.2: North American Preimplantation Genetics Diagnosis Market
    • 4.2.2: North American Preimplantation Genetics Diagnosis Market by End Use: Diagnostic Laboratories, Hospitals, Clinics, and Others
  • 4.3: European Preimplantation Genetics Diagnosis Market
    • 4.3.1: European Preimplantation Genetics Diagnosis Market by Type: Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single Gene Disorders, HLA Typing, Gender Selection, and Others
    • 4.3.2: European Preimplantation Genetics Diagnosis Market by End Use: Diagnostic Laboratories, Hospitals, Clinics, and Others
  • 4.4: APAC Preimplantation Genetics Diagnosis Market
    • 4.4.1: APAC Preimplantation Genetics Diagnosis Market by Type: Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single Gene Disorders, HLA Typing, Gender Selection, and Others
    • 4.4.2: APAC Preimplantation Genetics Diagnosis Market by End Use: Diagnostic Laboratories, Hospitals, Clinics, and Others
  • 4.5: ROW Preimplantation Genetics Diagnosis Market
    • 4.5.1: ROW Preimplantation Genetics Diagnosis Market by Type: Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single Gene Disorders, HLA Typing, Gender Selection, and Others
    • 4.5.2: ROW Preimplantation Genetics Diagnosis Market by End Use: Diagnostic Laboratories, Hospitals, Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Preimplantation Genetics Diagnosis Market by Type
    • 6.1.2: Growth Opportunities for the Global Preimplantation Genetics Diagnosis Market by End Use
    • 6.1.3: Growth Opportunities for the Global Preimplantation Genetics Diagnosis Market by Region
  • 6.2: Emerging Trends in the Global Preimplantation Genetics Diagnosis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Preimplantation Genetics Diagnosis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Preimplantation Genetics Diagnosis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: PerkinElmer Agilent Technologies
  • 7.2: Cegat
  • 7.3: Laboratory Corporation of America Holdings
  • 7.4: Illumina
  • 7.5: Invitae Corporation
  • 7.6: Pacgenomics
  • 7.7: Quest Diagnostics
  • 7.8: Natera
  • 7.9: Reproductive Genetic Innovations (RGI)